Charles Schwab’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-552,232
Closed -$663K 3729
2023
Q1
$663K Buy
552,232
+35,392
+7% +$78.7K ﹤0.01% 2863
2022
Q4
$734K Sell
516,840
-22,124
-4% -$47.5K ﹤0.01% 2885
2022
Q3
$1.32M Buy
538,964
+13,135
+2% +$43.8K ﹤0.01% 2709
2022
Q2
$1.19M Buy
525,829
+692
+0.1% +$2.58K ﹤0.01% 2727
2022
Q1
$3.53M Buy
525,137
+11,065
+2% +$94.6K ﹤0.01% 2445
2021
Q4
$4.65M Buy
514,072
+4,609
+0.9% +$42.8K ﹤0.01% 2385
2021
Q3
$5.15M Sell
509,463
-16,380
-3% -$180K ﹤0.01% 2363
2021
Q2
$6.75M Buy
525,843
+10,322
+2% +$142K ﹤0.01% 2201
2021
Q1
$7.29M Sell
515,521
-285,474
-36% -$3.93M ﹤0.01% 2114
2020
Q4
$8.54M Sell
800,995
-284,460
-26% -$2.58M ﹤0.01% 1952
2020
Q3
$8.29M Sell
1,085,455
-193,724
-15% -$1.42M ﹤0.01% 1811
2020
Q2
$7.75M Buy
1,279,179
+697,716
+120% +$3.44M ﹤0.01% 1792
2020
Q1
$2.05M Buy
581,463
+106,403
+22% +$901K ﹤0.01% 2270
2019
Q4
$5.02M Buy
475,060
+10,681
+2% +$94.8K ﹤0.01% 2010
2019
Q3
$5.2M Buy
464,379
+14,513
+3% +$172K ﹤0.01% 1938
2019
Q2
$4.12M Buy
449,866
+7,875
+2% +$82.2K ﹤0.01% 2067
2019
Q1
$4.89M Sell
441,991
-780,448
-64% -$5.46M ﹤0.01% 1989
2018
Q4
$3.04M Buy
1,222,439
+294,236
+32% +$1.05M ﹤0.01% 2159
2018
Q3
$4.18M Buy
928,203
+213,381
+30% +$1.56M ﹤0.01% 2148
2018
Q2
$8.54M Sell
714,822
-5,966
-0.8% -$79.8K 0.01% 1704
2018
Q1
$11.1M Buy
720,788
+87,674
+14% +$1.46M 0.01% 1421
2017
Q4
$10.4M Buy
633,114
+79,378
+14% +$1.53M 0.01% 1454
2017
Q3
$12.7M Buy
553,736
+56,957
+11% +$1.21M 0.01% 1242
2017
Q2
$13.9M Buy
496,779
+15,956
+3% +$441K 0.01% 1108
2017
Q1
$14.8M Buy
480,823
+41,258
+9% +$1.17M 0.01% 1034
2016
Q4
$11.1M Buy
439,565
+50,174
+13% +$1.18M 0.01% 1173
2016
Q3
$9.65M Buy
389,391
+41,732
+12% +$1.11M 0.01% 1192
2016
Q2
$8.63M Buy
347,659
+11,928
+4% +$307K 0.01% 1182
2016
Q1
$9.71M Buy
335,731
+11,287
+3% +$295K 0.01% 1074
2015
Q4
$9.76M Sell
324,444
-79,428
-20% -$2.7M 0.01% 1047
2015
Q3
$12M Buy
403,872
+16,568
+4% +$539K 0.02% 864
2015
Q2
$13.6M Buy
387,304
+133,829
+53% +$4.72M 0.02% 809
2015
Q1
$8.99M Buy
253,475
+92,788
+58% +$3.13M 0.01% 1069
2014
Q4
$5.57M Buy
160,687
+3,951
+3% +$139K 0.01% 1362
2014
Q3
$5.54M Buy
156,736
+989
+0.6% +$37.3K 0.01% 1278
2014
Q2
$6.26M Buy
155,747
+10,647
+7% +$408K 0.01% 1212
2014
Q1
$5.79M Buy
145,100
+15,672
+12% +$564K 0.01% 1220
2013
Q4
$4.27M Buy
129,428
+10,576
+9% +$330K 0.01% 1395
2013
Q3
$3.53M Buy
118,852
+10,262
+9% +$322K 0.01% 1451
2013
Q2
$3.74M Buy
+108,590
New +$3.36M 0.01% 1299

Other funds holding DBD

Charles Schwab's DBD Position: Q2 2023 in Review

Charles Schwab sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 552,232 shares — an estimated $663K sold.

Charles Schwab first reported a position in DBD in Q2 2013 and held it in 40 quarters. The position peaked at $14.8M in Q1 2017. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.

  • Charles Schwab reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
  • Charles Schwab sold 552,232 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $663K.
  • Charles Schwab first reported a position in Diebold Nixdorf Incorporated in Q2 2013 and held it in 40 quarters.
  • Charles Schwab's Diebold Nixdorf Incorporated position peaked at $14.8M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.

Based on Charles Schwab's 13F filing for Q2 2023, filed 10 Aug 2023.